As of the most recent data (June 2026), AVE.AX shows a inventory of $17K. That compares with $140K in the prior-year period — down 87.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVE.AX's inventory is now $17K (was $140K) — a 87.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Avecho Biotechnology Limited is outperforming or lagging.

Tracking AVE.AX's inventory over time shows whether Avecho Biotechnology Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $17K That compares with $140K in the prior-year period — down 87.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Avecho Biotechnology Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $17K) with ownership activity and broader fundamentals.

Avecho Biotechnology Limited's inventory is $17K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.